PASUT, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.642
AS - Asia 5.928
EU - Europa 3.836
AF - Africa 1.364
SA - Sud America 1.329
OC - Oceania 136
Continente sconosciuto - Info sul continente non disponibili 71
Totale 25.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.929
SG - Singapore 2.073
CN - Cina 1.112
IT - Italia 911
BR - Brasile 853
HK - Hong Kong 647
VN - Vietnam 598
DE - Germania 373
FI - Finlandia 352
FR - Francia 192
UA - Ucraina 178
PL - Polonia 174
RU - Federazione Russa 155
SE - Svezia 154
GB - Regno Unito 140
NL - Olanda 111
TR - Turchia 110
IN - India 92
AR - Argentina 90
JP - Giappone 87
BJ - Benin 76
AT - Austria 72
ES - Italia 68
IE - Irlanda 68
MX - Messico 68
ID - Indonesia 65
KR - Corea 65
EC - Ecuador 64
IQ - Iraq 59
ZA - Sudafrica 57
EG - Egitto 55
AE - Emirati Arabi Uniti 54
CA - Canada 54
IR - Iran 52
PK - Pakistan 51
MA - Marocco 50
CO - Colombia 49
UZ - Uzbekistan 49
PY - Paraguay 48
CR - Costa Rica 46
SI - Slovenia 46
TN - Tunisia 46
GR - Grecia 45
TH - Thailandia 44
CH - Svizzera 43
JO - Giordania 43
NI - Nicaragua 43
UG - Uganda 43
HN - Honduras 42
MZ - Mozambico 42
UY - Uruguay 42
BF - Burkina Faso 41
PE - Perù 41
VE - Venezuela 41
AL - Albania 40
BO - Bolivia 40
BY - Bielorussia 40
HR - Croazia 40
KE - Kenya 40
BE - Belgio 39
CI - Costa d'Avorio 39
LV - Lettonia 39
SA - Arabia Saudita 39
TW - Taiwan 39
IL - Israele 38
PA - Panama 38
PR - Porto Rico 38
PT - Portogallo 38
RO - Romania 38
XK - ???statistics.table.value.countryCode.XK??? 37
CZ - Repubblica Ceca 36
DO - Repubblica Dominicana 36
ET - Etiopia 36
MK - Macedonia 36
MN - Mongolia 36
TT - Trinidad e Tobago 36
YE - Yemen 36
DK - Danimarca 35
DZ - Algeria 35
MY - Malesia 35
NG - Nigeria 35
PH - Filippine 35
RS - Serbia 35
AM - Armenia 34
CY - Cipro 34
EE - Estonia 34
GH - Ghana 34
LU - Lussemburgo 34
MW - Malawi 34
SK - Slovacchia (Repubblica Slovacca) 34
AO - Angola 33
AU - Australia 33
AZ - Azerbaigian 33
CU - Cuba 33
GF - Guiana Francese 33
GN - Guinea 33
IS - Islanda 33
AF - Afghanistan, Repubblica islamica di 32
BD - Bangladesh 32
BS - Bahamas 32
Totale 23.752
Salva come PNG Salva come JPEG
Città #
Fairfield 1.501
Woodbridge 1.241
Singapore 1.044
Ashburn 999
Houston 884
Ann Arbor 827
Jacksonville 697
Chandler 691
Hong Kong 614
Wilmington 575
Seattle 546
Cambridge 501
Beijing 309
Santa Clara 303
Boardman 281
Princeton 252
Padova 244
Dong Ket 226
Roxbury 170
Medford 157
Ho Chi Minh City 146
Los Angeles 132
Munich 131
San Diego 131
Nanjing 128
Helsinki 124
Bytom 114
Des Moines 90
Hanoi 77
Cotonou 73
Buffalo 69
Milan 68
Guangzhou 65
New York 56
São Paulo 55
Vienna 52
Chicago 51
Tokyo 49
Dublin 46
Turku 46
Amman 43
Kampala 43
Tashkent 43
Istanbul 41
Managua 38
Hefei 37
Shanghai 37
Abidjan 36
Panama City 36
Nairobi 35
Ulan Bator 35
Venice 35
Shenyang 34
Montevideo 32
Riga 32
Yerevan 32
Baku 31
Conakry 31
Maputo 31
San José 31
Accra 30
Andorra la Vella 30
Brooklyn 30
Dakar 30
Nassau 30
Ouagadougou 30
Redondo Beach 30
Dili 29
Kigali 29
Nanchang 29
Norwalk 29
Warsaw 29
Addis Ababa 28
Belo Horizonte 28
Bishkek 28
Lilongwe 28
London 28
Lusaka 28
Rio de Janeiro 28
Tallinn 28
Havana 27
Mestre 27
Minsk 27
Nouakchott 27
Antananarivo 26
Bridgetown 26
Castries 26
Hebei 26
Johannesburg 26
Ljubljana 26
Willemstad 26
Bamako 25
Luanda 25
Podgorica 25
Reykjavik 25
Rome 25
Amsterdam 24
Libreville 24
Phnom Penh 24
Pristina 24
Totale 15.568
Salva come PNG Salva come JPEG
Nome #
Transgultaminase-Mediated Nanoarmoring of Enzymes by PEGylation 244
Site-selective enzymatic chemistry for polymer conjugation to protein lysine residues: PEGylation of G-CSF at lysine-41 241
Site-Specific Transglutaminase-Mediated Conjugation of Interferon α-2b at Glutamine or Lysine Residues 236
Molecular platforms for targeted drug delivery 232
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 231
(1-B-D-arabinofuranosyl)cytosine (Ara-C) polymer conjugates for controlled release 230
A Non-Covalent Antibody Complex for the Delivery of anti-cancer drugs 229
Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates 221
Anti-HER2 Super Stealth Immunoliposomes for Targeted-Chemotherapy 220
A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions 216
Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study. 215
Drug and protein delivery by polymer conjugation 215
Hyaluronic acid as a protein polymeric carrier: An overview and a report on human growth hormone 214
Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates 212
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines 209
A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone 200
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo 200
Chemical and Enzymatic Site Specific PEGylation of hGH 199
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer 197
Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates 196
Novel Super Stealth immunoliposomes for cancer targeted delivery of doxorubicin: an innovative strategy to reduce liver toxicity 195
Super Stealth immunoliposomes as a strategy to overcome liposome-induced liver toxicity 194
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 191
Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms 190
Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods 190
Covalent immobilisation of transglutaminase: stability and applications in protein PEGylation 185
PEGILAZIONE INNOVATIVA DEL KILLER TNF-APOPTOSIS INDUCED LIGAND (KILLER-TRAIL) 185
Overcoming Cancer Cell Drug Resistance by a Folic Acid Targeted Polymeric Conjugate of Buthionine Sulfoximine 185
Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease 185
Thiol-Activated Anticancer Agents: The State of the Art 180
PEGylated proteins as cancer therapeutics 179
Poly(L-glutamic acid)-co-poly(ethylene glycol) block copolymers for protein conjugation 179
Nanomedicines for the Delivery of Biologics 177
Multivalent and Flexible PEG-Nitrilotriacetic Acid Derivatives for Non-covalent Protein Pegylation 173
A new PEG-b-alanine active derivative for releasable protein conjugation 172
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. 171
A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery 171
Efficacy of PEGylated ciliary neurotrophic factor superagonist variant in diet-induced obesity mice 169
A novel PEG-haloperidol conjugate with a non-degradable linker shows the feasibility of using polymer-drug conjugates in a non-prodrug fashion 167
Transglutaminase and Sialyltransferase Enzymatic Approaches for Polymer Conjugation to Proteins 167
Conjugation of hyaluronan to proteins 166
Inulin-d-α-Tocopherol Succinate (INVITE) Nanomicelles as a Platform for Effective Intravenous Administration of Curcumin 165
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 163
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates 157
Abstract B192: The EPR effect of CDP-tubulysin in the recurrence of lung and pancreatic cancers 155
PEG-Ara-C conjugates for controlled release 154
Polyoxazoline: chemistry, properties, and applications in drug delivery 153
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates 148
Enzymatic approaches to new protein conjugates 148
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes 147
Basic strategies for PEGylation of peptide and protein drugs 146
Detection of sites of infection in mice using 99mTc-labeled PN(2)S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study. 145
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor 145
PEG-epirubicin conjugates with high drug loading 143
PHEA-Graft-Polymethacrylate Supramolecular Aggregates for Protein Oral Delivery 143
Pegylation for improving the effectiveness of therapeutic biomolecules 142
Polyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injury 142
LIPOSOMAL SYSTEM WITH KILLER TNF-APOPTOSIS INDUCED LIGAND (KILLERTRAIL), PRO-APOPTOTIC-DIRECTING 141
PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties 139
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. 137
PEG-doxorubicin conjugates: Influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity 136
PEGylation: Posttranslational bioengineering of protein biotherapeutics 136
Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol 135
State of the art in PEGylation: The great versatility achieved after forty years of research 135
Development of a new hyaluronic acid-calcitonin conjugate for the local treatment of osteoarthritis 135
Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol 134
PEGylation, successful approach to drug delivery. 133
Protective Effect of Intravenous High Molecular Weight Polyethylene Glycol on Fatty Liver Preservation 133
A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: Chondro-protective effect in a rabbit model of early OA 132
Improvement of Drug Therapy by Covalent PEG Conjugation: An Overview From a Research Laboratory 131
The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules 131
Indirect 99mTc-labeled UBI Using PN2S-PEG Moiety 129
Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers 129
Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine ligand with poly(ethylene glycol) 128
Antitumoral activity of peg-gemcitabine prodrugs targeted by folic acid 126
Synthesis and characterization of poly(2-ethyl 2 oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates? 126
Polymers for Protein Conjugation 126
Polyethylene glycol rinse solution: An effective way to prevent ischemia-reperfusion injury. 126
Recent Developments in Hyaluronic Acid-Based Nanomedicine 125
Folic acid-targeted paclitaxel-polymer conjugates exert selective cytotoxicity and modulate invasiveness of colon cancer cells 125
The role of high molecular weight hyaluronic acid in mucoadhesion on an ocular surface model 124
PEG conjugates in clinical development or use as anticancer agents: an overview 124
Site-Specific Pegylation of G-CSF by Reversible Denaturation 124
Farmacodinamica dei farmaci biologici 124
The Protein Engineering Approach Differentiates the Functional Importance of Carbohydrate Moieties of Interleukin-5 Receptor α 124
Polymer-Protein Conjugates From PEGylation and Beyond 124
Enzymatic Formation of PEGylated Oligonucleotides 123
Comparison of classical, stealth and super-stealth liposomes for intravenous delivery of lumefantrine: Formulation, characterization and pharmacodynamic study 123
Protein PEGylation, basic science and biological applications 122
Polyethylene glycol and a novel developed polyethylene glycol-nitric oxide normalize arteriolar response and oxidative stress in ischemia-reperfusion 122
99mTechnetium labeling of pegylated PN2S ligand in presence or absence of tin (II) 122
PEG: an useful technology in anticancer therapy 122
NEW PEGYLATED CHELATING AGENT (mPEG-PN2S) SHOWED AN EASY LABELING METHOD WITH 99mTECHNETIUM USEFUL FOR TUMOUR DIAGNOSIS 121
Liver graft washout prevents against reperfusion Injury: protective effects on glycocalyx and cytoskeleton 120
A new method for high selective TGase-mediated PEGylation of salmon calcitonin and human growth hormone 120
Peg-doxorubicin conjugates with high loading 119
PEGylated α Interferons: two different strategies to achieve increased efficacy 119
Polymer-Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action 118
Kinetic Interaction Analysis of Human Interleukin 5 Receptor α Mutants Reveals a Unique Binding Topology and Charge Distribution for Cytokine Recognition 118
PEGylation of proteins as tailored chemistry for optimized bioconjugates 117
Totale 15.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.391
article - articoli 47.751
book - libri 415
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 2.985
selected - selezionate 0
volume - volumi 8.173
Totale 136.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.612 0 0 0 0 50 126 48 215 313 229 261 370
2021/20222.344 70 303 292 103 117 97 134 312 102 34 237 543
2022/20231.579 380 106 41 143 274 207 19 103 181 19 71 35
2023/20241.055 63 160 100 86 60 56 78 50 64 116 107 115
2024/20254.351 18 274 303 168 640 121 191 424 368 150 739 955
2025/20268.429 631 1.468 2.502 2.866 962 0 0 0 0 0 0 0
Totale 25.462